首页> 外国专利> genetically modified plasmodium vivax antigen sequences, vaccine compositions containing recombinant proteins and recombinant viruses expressing these antigens, and dose-boosting malaria vaccination method

genetically modified plasmodium vivax antigen sequences, vaccine compositions containing recombinant proteins and recombinant viruses expressing these antigens, and dose-boosting malaria vaccination method

机译:基因修饰的间日疟原虫抗原序列,含有重组蛋白和表达这些抗原的重组病毒的疫苗组合物以及提高剂量的疟疾疫苗接种方法

摘要

The present invention relates to the construction of modified genetic sequences, which comprise sequences for antigens (DBP-PA, DBP-AM, DBP-MT, AMA-1, CS and MSP-1 ) of Plasmodium vivax, the corresponding recombinant proteins encoded by said sequences as well as genetically modified viruses that express these recombinant antigens. In addition, the present invention refers to a method of prime-boost vaccination using adenoviral or poxviral vectors, purified proteins for immunization of mammals and vaccine compositions to be used as vaccines against malaria.
机译:本发明涉及修饰的遗传序列的构建,其包含间日疟原虫的抗原(DBP-PA,DBP-AM,DBP-MT,AMA-1,CS和MSP-1)的序列,这些序列以及表达这些重组抗原的转基因病毒。另外,本发明涉及一种使用腺病毒或痘病毒载体,用于免疫哺乳动物的纯化蛋白和用作抗疟疾疫苗的疫苗组合物的初免-加强疫苗接种的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号